11
Participants
Start Date
November 29, 2017
Primary Completion Date
February 22, 2019
Study Completion Date
February 22, 2019
Vedolizumab
Vedolizumab IV infusion
University of North Carolina at Chapel Hill, Chapel Hill
Feinberg School of Medicine Northwestern University, Chicago
Carle Foundation Hospital, Urbana
Baylor College of Medicine, Houston
University of Colorado, Aurora
Atlantic Health System, Morristown
Vanderbilt University Medical Center, Nashville
Lead Sponsor
Takeda
INDUSTRY